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E-mail address: wolfgang.meier@unibas.ch (W. MeIn various pathological conditions an advantage may be gained by reinforcing an intrinsic organis-
mal response. This can be achieved, for example, by enzyme replacement therapy, which can amplify
speciﬁc, intrinsic activities of the organelles. In this respect, polymeric nanoreactors composed of
vesicles that encapsulate an enzyme or a combination of enzymes in their cavities represent a novel
approach in therapeutic applications because they behave like simpliﬁed organelles. As compart-
ments, polymeric vesicles possess a membrane that is more stable than the corresponding lipid
membrane of liposomes, with the dual role of protecting enzymes and simultaneously allowing
them to act in situ. A complex scenario of requirements must be fulﬁlled by enzyme-containing
polymeric nanoreactors if they are to function under biological conditions and serve to model
organelles. Nanoreactors are described here in terms of the existing models and the challenges faced
in developing artiﬁcial organelles for therapeutic applications. We will focus on describing how
polymeric vesicles can be used to provide a protected compartment for enzymatic reactions, and
serve as simpliﬁed organelles inside cells.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cellular organelles are intracellular compartments with speciﬁc
functions that are crucial to the life of the cell. Each organelle pro-
vides precise functions inside cells, for example mitochondria are
involved in cellular respiration, ribosomes in protein production,
etc. Organelles possess sets of enzymes that enable them to pro-
duce, transform, and repair the cellular ‘‘molecules of life’’ and they
are protected by their own selective membranes. These lipid mem-
branes serve as an interface that controls interactions and intracel-
lular communication. In addition, they provide a compartment
(internal) that allows spatial control of different functions. It is
thus essential to characterize the properties of the membrane bar-
rier as well as the changes that occur when membrane proteins
incorporated in the lipid membrane are activated or blocked. In
this context, artiﬁcial membranes and vesicles are of increased
interest as model systems that mimic biomembranes and organ-
elles, or even whole cells.
In recent years, membranes and vesicles from amphiphilic block
copolymers in particular have garnered considerable attention be-
cause they are considered to be higher molar mass homologues ofchemical Societies. Published by E
ier).conventional lipids that self-assemble in select solvents into super-
structures such as micelles and vesicles [1–4]. However, due to
their higher molar mass, they frequently form larger aggregates
with lower dynamics. For example, membrane structures com-
posed of amphiphilic block copolymers may be up to 10 times
thicker than those of natural bilayer-forming phospholipids. As a
result, they frequently display considerably higher mechanical
stability than conventional lipid bilayers, supporting their medical
applications in diagnostic approaches, drug delivery, and as
biosensors [1–3,5].
Combining polymeric vesicles with bio-entities, such as pro-
teins and enzymes, represents a necessary step towards complex
protein-synthetic nanosystems [6] that can mimic organelles.
Recently, polymeric vesicles are also raising increasing interest as
compartments for enzymatic reactions, because their aqueous
cavities serve to protect catalytic medium with encapsulated
enzymes, as part of the so-called nanoreactor concept [7–11].
Nanoreactors that act as artiﬁcial organelles are designed for ther-
apeutic applications in order to actively produce drugs to ﬁght
disease (enzyme replacement therapy) and to enhance the activity
of existing organelles in cases of cellular stress (Fig. 1). In the
following, we focus primarily on necessary conditions and require-
ments for nanoreactors to mimic organelles for therapeutic
applications.lsevier B.V. All rights reserved.
Fig. 1. Schematic representation of polymeric nanoreactors as artiﬁcial organelles:
(a) polymeric nanoreactors, (b) schematic representation of a cell, (c) transmission
electron micrograph of intracellular nanoreactors, (d) LSM-image of THP-1 cells
containing nanoreactors (reprinted with permission from Ref. [75]).
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Polymeric vesicles, so-called polymersomes, can be regarded as
synthetic analogs of lipidic vesicles and are based on the self-
assembly behavior of amphiphilic, and thus membrane-forming,
block-copolymers. In recent years the ‘library’ of biomimetic,
membrane-forming polymers has been extended considerably by
introducing various peptides [12–15], polysaccharides [14,16,17],
and zwitterionic- [18], sensor-responsive- [19,20] or oxidation-
sensitive polymers as new building blocks. Apart from amphiphilic
diblock and symmetrical triblock copolymers, amphiphilic asym-
metric triblock copolymers are also enjoying increasing interest,
due to their ability to generate asymmetric membranes that – in
certain cases – appear to undergo pH-induced ‘breathing’ [21] or
membrane inversion [17,22–24]. These examples nicely demon-
strate the versatility of polymer chemistry that allows tailoring
properties and potential functions of resulting membranes. In
addition, the wealth of structures and properties can be further ex-
panded by mixing different block copolymers or lipids and block
copolymers to create regions with well-deﬁned functionality in a
polymer membrane. This can be used to control vesicle size [25]
or average membrane thickness [26].
Membrane thickness depends on the chemical nature, the
length of the polymer blocks, the hydrophobic/hydrophilic ratio
[27,28], the experimental conditions and the molecular weights
of the polymers. It is usually a multiple of that of a lipid membrane
and can be up to twice as much [29], and leads to high structural
stability [30].
Polymer membranes are quite tolerant to chemical modiﬁcation
as a result of the macromolecular nature of the basic building
blocks. This feature has been exploited to couple biomolecules or
functional groups that are suited for molecular recognition to the
surface of vesicles [31–35]. Correspondingly, modiﬁed polymer
vesicles can selectively bind to receptors on the surface of cells
for targeting approaches [18]. In addition, block copolymer vesicles
can be loaded with hydrogels. As with the cytoskeleton of cells, in
this case mechanical deformation behavior is controlled primarily
by the encapsulated hydrogel [36].
Therefore, it is not surprising that polymer vesicles are of
increasing interest as novel carriers in controlled and targeted
delivery of drugs, one of the most important current goals in drug
delivery [5]. However, we will not include the use of polymeric
vesicles as drug carriers here, but rather concentrate on their use
to provide a protected compartment for enzymatic reactions and
thus on serving as nanoreactors mimicking natural organelles.3. Polymer nanoreactors
In a nanoreactor, encapsulated enzymes act in situ within
polymeric vesicles, thus eliminating the necessity of their release
from the polymer cage, as with the conventional drug release car-
rier. This fact avoids well-known drawbacks of uncontrolled re-
lease, or release in other biological compartments than those
desired.
To control the exchange of enzyme substrates and products
with the environment, either block copolymers forming porous
membranes or channel-forming proteins inserted into the vesicle
walls were used [37,38]. Remarkably, despite the thickness and
mechanical stability of synthetic block copolymer membranes,
they permit functional insertion of membrane proteins that pro-
vide controlled permeability [39,40]. Computer simulations have
conﬁrmed transmembrane proteins can be incorporated in poly-
mer membranes even if there is a large thickness mismatch. This
is due to the exceptionally high compressibility of the polymer
membranes, together with the polydispersity of the polymers
[41]. For example, transmembrane transport has been demon-
strated, mediated by various pore proteins incorporated success-
fully in polymer membranes. The non-selective transport of
various molecules (antibiotics, ﬂuorescent dyes) into/out-of poly-
meric nanoreactors was achieved with reconstituted passive diffu-
sion channels such as OmpF [9,42], while speciﬁc transit was
achieved by reconstituting selective transporters: LamB, AqpZ,
Tsx and Complex I [38,40,43,44].
Nanoreactors have been studied extensively as compartments
that protect speciﬁc reactions, and only a few studies have consid-
ered their use in cells. In this respect, antioxidant nanoreactors
encapsulating SOD were designed [37]. The antioxidant nanoreac-
tors permit the transport of superoxide anions through the mem-
brane, making possible their detoxiﬁcation inside the vesicles,
where SOD remains stable for weeks. Other examples include
encapsulation of trypsin [45,46], glucose oxidase [8] and Candida
antarctica Lipase B [10] inside polymer vesicles with porous
membranes.
Nanoreactors for enzymatic conversions and with mediated
transport by channel proteins have been studied with teams of en-
zymes: b-lactamase [47], acid phosphatase [42,48], horseradish
peroxidase [49], nucleoside hydrolase [40], thymidine phosphory-
lase [50]. Based on nanoreactors that contain a single type of en-
zyme, more complex systems have been proposed involving two
different enzymes present inside nanoreactors [51] or occupying
different locations in the nanoreactor system (inside, within the
membrane, or attached onto the membrane of the vesicle) [52].
While the nanoreactors containing one type of enzyme can be
used directly in enzyme replacement therapy, more sophisticated
nanoreactors can function as artiﬁcial organelles that perform
complex reactions similar to cascade reactions that take place in
cells, for example metabolic pathways.4. Requirements in the design of artiﬁcial organelles
There are various requirements that require simultaneous ful-
ﬁllment in order for a polymer nanoreactor to mimic an organelle,
both from the point of view of components – polymer vesicle and
enzyme(s) – and that of the entire system. While a polymer vesicle
must be generated using block copolymers to form a protected
compartment and allow for transport through the membrane, the
activity of encapsulated enzymes should remain preserved and
their concentrations high enough to fulﬁll the intended function.
Overall, of course, the nanoreactor needs to be taken-up by cells,
preserve its integrity, be non-toxic, and simultaneously act in the
inner cellular space, mimicking natural organelles.
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bilayers
In order to serve as compartments to encapsulate enzymes in a
manner similar to lipid bilayers, there are speciﬁc requirements
imposed on the chemical nature of copolymer blocks and the
membrane of a generated vesicle. These include reproducibility
and a controllable process to generate vesicles with a stable, per-
meable and ﬂexible membrane, allowing functional reconstitution
of membrane proteins.
Vesicles are obtained through the self-assembly of amphiphilic
block copolymers in a manner similar to lipidic vesicles (lipo-
somes), thus they are enclosed by polymer bilayers [1]. As pre-
sented above, the greater stability of a polymer membrane
compared to lipid bilayers represents an advantage, promoting
the use of polymer compartments in medical applications, where
the polymer compartment is intended to preserve its integrity
and encapsulated content.
Based on the variety of block copolymers used, permeability of
polymeric membranes ranges from block copolymers that form
nanoporous membranes [8,11,37,45,46,52] to highly impermeable
block copolymer membranes, in which case the functional inser-
tion of channel proteins, such as OmpF, LamB, maltoporin and aqu-
aporin [38,40,44,53,54] enabled controlled permeability. Insertion
of channel proteins allows transfer of substrates/products of
appropriate molecular weights into and from the vesicle. For
example, insertion of OmpF permits passive transport of molecules
up to 600 Da, while biopores such as gramicidin allow the trans-
port of ions. But insertion of channel proteins does not allow the
escape of encapsulated enzymes/proteins, as is the case with the
lipid membrane of organelles.
Another parameter related to membrane permeability arises
from membrane ﬂuidity, which also depends on the molecular
weight [55]. High ﬂuidity is essential in order to adapt the speciﬁc
geometric and dynamic requirements of membrane proteins, when
their insertion becomes necessary for the passive diffusion of a
compound that cannot pass through the membrane on its own.
For example, ﬂexible poly(2-methyloxazoline)-poly-(dimethylsi-
loxane)-poly(2-methyloxazoline), (PMOXA-PDMS-PMOXA), mem-
branes successfully adapted to accommodate NADH-quinone
oxidoreductase (Complex I), preserved activity and mediated an
electron-transfer from the environment inside the membrane
[43]. Interestingly, the activation of delipidated Complex I inside
the polymer membrane depended on the variation of the hydro-
phobic/hydrophilic ratio of polymer blocks. This indicates that a
ﬂexible synthetic membrane is able to provide the speciﬁc envi-
ronment for a sensitive membrane protein to allow normal func-
tioning, similar to a biological membrane.
Generally speaking, simulation of organelles requires a process
of reproducible vesicle formation, with well-controlled size and
high loading capacities. This requires a detailed understanding of
the formation process and characterization of the different inter-
mediates, as well as establishing structure-property relationships
[12,56]. For example, poly(2-vinyl pyridine-b ethylene oxide) block
copolymers undergo a thermotropic transition from cylinders to
vesicles [57]. This not only permits tracing the topological pathway
directly during the transition, but also the precise control of the
size of the vesicles. Recently, an unexpected correlation between
vesicle size and membrane thickness has also been reported [58].
4.2. Payload requirements inside an artiﬁcial organelle
The requirements related to enzymes/proteins in order to com-
bine them with polymer vesicles and generate artiﬁcial organelles
are mainly the preservation of activity/function and high encapsu-
lation/insertion efﬁciency.The activity of a nanoreactor is determined by the rate of prod-
uct released. Therefore, it is important that the activity of the en-
zyme entrapped be preserved during the encapsulation
procedure. In the case of polymersomes, encapsulation techniques
such as ﬁlm hydration or solvent displacement methods are em-
ployed [59]. Both categories of techniques may impose mechanical
or chemical stress on the enzymes, with potential loss of activity.
Studies on the catalytic properties of nanoreactors have proven
that the enzymes not only maintain their activity inside [42], but
they lower the Km, due to favorable interactions with the polymeric
membrane [46]. For example, acid phosphatase encapsulated in
poly(2-methyloxazoline)-poly-(dimethylsiloxane)-poly(2-methyl-
oxazoline) vesicles with OmpF as a channel protein within the
polymer membrane preserved its activity as compared to the
activity of the enzyme in solution [42]. Trypsin encapsulated inside
polymer vesicles enhanced its catalytic properties signiﬁcantly: the
Km of 26.6 ± 2.5 lM of the free enzyme decreased to 1.12 ± 0.18 lM
calculated after encapsulation [46]. It has been reported that the
enzymatic activity of trypsin was inﬂuenced by vesicle size; the
smaller the vesicle the greater the activity of the enzyme, indicat-
ing the advantageous interactions of the enzymes with the poly-
mer membrane [46].
The number of molecules encapsulated is a parameter that
inﬂuences the efﬁciency of a nanoreactor directly. Encapsulation
efﬁciencies from 4.5% for hemoglobin encapsulated in polymer-
somes prepared by ﬁlm hydration [60] to 98% for a-chemotrypsin
encapsulated in polymeric vesicles produced by the layer-by-layer
technique [61] have been achieved. Antioxidant nanoreactors con-
taining SOD have been investigated in relation to block copolymer
chemical properties, and encapsulation efﬁciencies were con-
trolled by means of the ratio of the polymer blocks [62]. Encapsu-
lation efﬁciencies between 11% and 32% were obtained, but these
could not be directly related to block copolymer block length or
to the size of the vesicles formed by the block copolymers [62].
High encapsulation efﬁciencies are often desired. However,
when enzymes fully retain their activities within vesicles, the max-
imum number of enzymes encapsulated is not of great relevance.
Therefore, the activity of a nanoreactor can be changed by tuning
the amount of the enzyme encapsulated.
4.3. Requirements of nanoreactor when used as artiﬁcial organelles
The requirements for a nanoreactor to serve as an artiﬁcial orga-
nelle are: (i) a morphology and a range of diameters compatible
with the intracellular space, (ii) efﬁcient up-take by cells, (iii) pres-
ervation of integrity and content, and (iv) fulﬁllment of its function
in the inner space of the cell.
The self-assembly of amphiphilic block-copolymers creates
morphologies that depend on the chemical nature of the block-
copolymer and on the method used to generate the vesicles
[3,59]. For cell speciﬁc applications, it has been shown that nano-
meter-sized polymeric vesicles can be used to create complex
intracellular systems, while the importance in terms of usage as
delivery tools for therapeutic drugs or diagnostic agents is indis-
putable [3,6]. In terms of morphology, the geometry of a sphere
closely approximates the morphology of an ideal polymersome
nanoreactor, making it obvious that volume is maximized as
compared to surface area. In this respect, using hollow spheres to
create reaction vessels is very well suited to highly efﬁcient encap-
sulation. Therefore, these nanoreactors act as nanometer-sized
reaction compartments, where one or several different enzymes
are encapsulated and shielded from proteolytic attack, simulta-
neously facilitating their activity in situ [37,51].
Besides reference to the optimal geometry in the design of a
nanoreactor, cell uptake behavior has also been shown to be
dependent on the morphology and size of nanoparticles [63]. In
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polymersome surface topology have been deliberately varied in
order to ﬁne-tune uptake behavior [64–66]. But these studies were
driven for optimization of drug delivery carriers, where polymer-
somes collapse upon entry into the cell. On the contrary, nanoreac-
tors should not collapse but should remain intact over a long
period of time in order to carry out enzymatic reactions.
The integrity of nanoreactors based on rugged membranes is
therefore a crucial requirement for any application as artiﬁcial
organelles under cellular conditions. A possible way to fulﬁll this
prerequisite was demonstrated by the encapsulation of calcein
by PMOXA-PDMS-PMOXA nanovesicles [45]. Release studies of
calcein-internalized nanoreactors have shown that structural
stability was maintained even after 48 h. (Fig. 2A)
In addition to ensuring structural stability, it is important to
provide optimal reaction conditions inside the polymeric cavity
to maintain enzyme functionality. Activity tests under cellular con-
ditions are absolutely necessary to address such an important fac-
tor. Such tests were performed with nanoreactors functionalized
with a cell permeable peptide, and encapsulated with horseradish
peroxidase (HRP) (Fig. 2B) [35]. For these activity measurements,
the substrate 3,30,5,50-tetramethylbenzidine, which can easily dif-
fuse through lipid-membranes, was oxidized by HRP located inside
the nanoreactor, and the oxidized product was detected by UV/VIS
spectroscopy. 75% of HRP activity was maintained 4 hours after
internalization and even after 16 hours, 42% of the initial activity
was preserved. Great attention was also paid to the necessity of
activity measurements of enzymatic cascade reactions inside poly-
meric nanocontainers, where oxidative stress, induced by paraquat
in THP-1 cells, was successfully lowered by superoxide dismutase/
lactoperoxidase co-encapsulated nanocontainers (Fig. 2C) [51].
Enzymatic activity of lactoperoxidase over time in bulk wasFig. 2. Uptake and stability of different nanoreactor systems used as artiﬁcial organel
incubation time: (a) 2 h, (b) 24 h, (c) 36 h, (d) 48 h (reprinted with permission from Ref
3,30 ,5,50-tetramethylbenzidine conversion in time after cell uptake. reprinted with permi
take and activity of SOD-LPO-containing nanocontainers as artiﬁcial organelles. Transmiss
loaded nanocontainers without OmpF, and treated with amplex red and paraquat; (b) TH
and treated with amplex red; (c) THP-1 cells pre-incubated with SOD-LPO-loaded nanoco
with permission from Ref. [51]. Copyright Wiley-VCH Verlag GmbH & Co. KGaA).compared to that obtained inside polymeric vesicles. After 60 days,
the activity of free lactoperoxidase decreased to 40%, while its
enzymatic activity was still 70% when encapsulated inside poly-
meric vesicles. Enzymatic activity was also maintained after cellu-
lar uptake and led to increased cell viability under the condition of
oxidative stress. This combination of enzymes, simultaneously co-
encapsulated in polymeric vesicles to perform a complex cascade
reaction in order to mimic natural processes, is a big step toward
highly efﬁcient artiﬁcial organelles.
5. Cellular interactions of polymeric nanoreactors
Due to the chemical versatility of copolymer blocks, it is possi-
ble to generate polymersomes that overcome cellular barriers in
order to improve the delivery of various therapeutic proteins. In
this respect, it is very important to investigate the interactions of
nanoreactors with biological systems, such as cells, tissues, animal
models. Although various nanoreactors have been reported as
model systems for catalytic reactions, few studies have shown
the inﬂuence of physico-chemical properties of polymersomes on
cellular interactions. For example, it has been demonstrated that
physico-chemical parameters, such as size of polymersomes,
surface properties, block lengths of the copolymers, and interac-
tions with serum proteins inﬂuence cellular integration of the
polymersome [66]. Tuning the physico-chemical properties of
polymersomes can induce an improvement in cellular uptake,
intracellular trafﬁcking and biodistribution, depending on the
speciﬁc application. Understanding the intracellular fate of poly-
mersomes, such as internalization kinetics, intracellular trafﬁcking,
and biodistribution and biocompatibility, are important to the
design of more efﬁcient nanoreactors as artiﬁcial organelles for
therapeutic applications.les. (A) Stability of intracellular functionalized polymeric vesicles as a function of
. [45]). (B) Activity of intracellular HRP-loaded-tat-polymersomes visualized by the
ssion from Ref. [35], Copyright Wiley-VCH Verlag GmbH & Co. KGaA. (C) In vitro up-
ion and confocal ﬂuorescence image of (a) THP-1 cells pre-incubated with SOD-LPO-
P-1 cells pre-incubated with SOD-LPO-loaded nanocontainers reconstituting OmpF,
ntainers reconstituting OmpF, and treated with amplex red and paraquat (reprinted
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The size of a polymersome is a limiting factor that affects the
internalization pathway and the kinetics inside cells. Different poly-
mersomes at a size range of 100–400 nm showed size-dependant
uptake in cells, with faster uptake for smaller size (100 nm) and
slower kinetics for larger polymersomes (400 nm) [66]. Recently, a
mixture of two different copolymer systems, poly(2-(methacryloyl-
oxy)ethyl phosphorylcholine)-co-poly(2-(diisopropylamino)ethyl
methacrylate) and poly(ethylene glycol)-co-poly(2-(diisopropyl-
amino)ethyl methacrylate) (PMPC–PDPA and PEG–PDPA) was
shown to phase-separate into domains in polymersomes. Interest-
ingly, the size of the domains was reported to have a greater impact
on uptake kinetics. The rate of uptake was faster for the phase-sep-
arated domain size of  40 nm compared to 10 nm-sized domains
[66]. In general, objects at a size of 30–40 nm have a higher rate of
uptake, in line with a report relating the domain size of such poly-
mersomes to uptake. However, as the type of cell also plays a vital
role in uptake and kinetics, it is difﬁcult to provide a generalized,
deﬁnitive rule on internalization and kinetics for a speciﬁc size and
type of polymersome that applies to all kinds of cells.
5.2. Biodistribution
The charges at the membrane surface play an important role in
in vivo biodistribution, as shown for both lipidic carriers [67] and
polymeric systems [68,69]. The role of surface charges is based
on their interaction with opsonin and serum proteins, and affects
circulation kinetics and biodistribution. While binding efﬁciency
of neutral PEG-based polymersomes with serum proteins is low,
polymersomes made of PMPC-PDPA exhibit higher interaction,
due to the presence of different charges on PMPC [70]. In animal
models, most of the anionic polymersomes were accumulated in li-
ver and only a few were observed in the spleen. In the case of neu-
tral polymersomes, more accumulation was observed in liver and
spleen, while lower accumulation was found in other organs, sug-
gesting a different biodistribution. The circulation kinetics of anio-
nic polymersomes is shorter than that of neutral polymersomes,
due to the presence of speciﬁc receptors on liver cells that recog-
nize anionic molecules and clear them from circulation in shorter
times [71]. However, more detailed studies of charged polymers
used as building blocks for nanoreactors and speciﬁc to a cellular
environment are necessary for a signiﬁcant advance to occur in
terms of medical applications.
5.3. Circulation kinetics
In the serum, polymersomes can be readily recognized by
opsonin and complement proteins, which leads to phogocytic ac-
tion by the cells and elimination from the blood stream by the
immune system. Indeed, charged polymersomes have shown
higher interaction with serum proteins as compared to those
without charge [70]. Hydrophobicity is another key parameter
in the higher afﬁnity to opsonin. PEG is most commonly used
as the hydrophilic part of the polymersome and acts as a protein
repellent, thereby enhancing time in circulation [72]. Polymer-
somes made of PMOXA-PDMS-PMOXA were reported to have
very low serum protein binding capacity and a low rate of accu-
mulation in liver and spleen, due to the presence of PMOXA as
the hydrophilic block with neutral charge [45]. In addition, the
size of polymersomes can also inﬂuence serum protein binding
capacity. Polymersomes at a size of more than 100 nm have
shown a longer time in circulation as compared to smaller sized
polymersomes [73]. By avoiding recognition by serum proteins,
polymersome will improve circulation kinetics and therefore
higher therapeutic efﬁcacy can be obtained.5.4. Endosomal escape
Designing polymersomes that promote endosomal escape is an
essential criterion for fully functional nanoreactors to act as artiﬁ-
cial organelles that will not degrade or release contents into bio-
logical systems. Most polymersomes are readily internalized by
endocytosis and proceed to lysosomal compartments, where deg-
radation takes place [66,74]. Various strategies have been followed
to foster endosomal escape, including polymersome surface func-
tionalized with cell penetrating peptides and pH responsive struc-
tural rearrangement of polymersomes in acidiﬁed endosomal
compartments. In most cases, such endosomal escape is demon-
strated by the release of encapsulated materials into the cyto-
plasm, or such a release of the intact polymersomes is speculated
to have occurred [35,66]. To the best of our knowledge, no direct
experimental evidence exists thus far as to the intracellular local-
ization of intact nanoreactors after escape from endosomes. How-
ever, the endosomal escape of intact forms of PMOXA-PDMS-
PMOXA-based polymersomes into the cytoplasm has been seen.
Furthermore, time-dependant release of polymersomes from endo-
somes to cytoplasm was observed through transmission electron
microscopy analysis [75].
Studying internalization pathways is also an essential step to
facilitate endosomal escape, because different internalization path-
ways require different approaches. For instance, internalization of
polymersomes by caveolae-mediated endocytosis does not lead
to acidiﬁed endosomes. Therefore, pH sensitive release and escape
of polymersomes is not an appropriate strategy for endosomal
escape. In addition, macropinocytosis forms leakier macropino-
somes, enabling endosomal escape with less effort than clathrin-
mediated endocytosis [76].
5.5. Toxicity
A risk assessment for nanoreactors in biological systems is cru-
cial for exploring therapeutic applications. The most limiting
requirements for the chemical nature of copolymers are the avoid-
ance of non-speciﬁc, systemic or off-target toxicity while being
biocompatible and biodegradable [77]. In this respect polyanhy-
drides, PMOXA-PDMS-PMOXA, poly(methacrylate) (PMA), and
PEG have very low cytotoxicity [5,50,78], and therefore are suitable
as building units of artiﬁcial organelles. On the contrary, even if
copolymers such as poly(N-isopropylacrylamide) or diethylamino-
ethylcellulose-dextran generate vesicles with appropriate proper-
ties, their toxicity prevents them from being used as biosafe
membrane building blocks [79].
In addition, there are other factors, such as the type of assay and
type of cells, that can affect toxicity assessment, and therefore
should be carefully considered. For example, an MTT assay is a con-
ventional toxicity assay for pharmaceutical compounds and is used
for nanoreactors as well. This method is known to exhibit a cross
reaction between MTT and the superoxide radicals produced by
NADPH oxidase, which is a side reaction in phogocytic cells
(THP-1, macrophages), to provide a cellular defense mechanism,
leading to false positive results [50]. In such cases, alternative tox-
icity assays, such as the lactose dehydrogenase assay or the use of
other cell lines, may be useful. However, considerable attention
should be paid to the selection of the appropriate assay or cell type
prior to an experiment.
Polymersomes based on poly(ethylene oxide)-poly(2-(diisopro-
pylamino)ethyl methacrylate)-poly(dimethyl acrylamide) and poly
(g-benzyl-L-glutamate)-K showed no toxic effects on HDF cells and
Caco-2 cells, respectively, after 48 h [80,81]. However, we mention
that the low concentration of polymer (0.5–10 lg) used in [81]
does not allow any provision of a clear toxicity assessment. A high
polymer concentration (on the order of 200 lg–1 mg) is necessary
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order to be relevant form the toxicological point of view. The
majority of polymersomes were tested for cytotoxicity only
through an MTT assay. The toxicity assessment of nano size objects
in general is still in its infancy and, in this respect, a toxicity eval-
uation in animals is necessary for an adequate risk assessment of
engineered nano-objects, including polymersomes.
5.6. Biocompatibility
Biocompatibility of the polymersomes is one of the major con-
cerns in evaluating bio medical application, particularly for the use
of nanoreactors as artiﬁcial organelles intended for in vivo applica-
tion. Generally, biocompatibility is deﬁned as the immunological
inertness of a material or, in other words, no immunological
response by biological system to the materials. Note that toxicity is
often compared with biocompatibility, but toxicity represents only
the lethal effect on cells (cytotoxicity) caused by the nanoreactors.
If nanoreactors are not toxic, they need not necessarily also be bio-
compatible, and the two are different phenomena related to the cel-
lular response induced by nanoreactors. For example, while free
thymidine phosphorylase induces the secretion of inﬂammatory
mediators such as cytokines, leading to acute immune response in
macrophages, encapsulation inside nanoreactors based on PMOX-
A-PDMS-PMOXA copolymers show no inﬂammatory response. This
clearly demonstrates that nanoreactors certainly protect enzymes
from the immune system and can be referred to as biocompatible.
Similarly, no nitric oxide production was observed in PMOXA-
PDMS-PMOXA polymersomes when incubated with macrophages,
indicating the absence of inﬂammatory conditions [50]. The
immature dendritic cells incubated with poly(ethylene oxide)-
poly(butadiene) polymersomes did not lead to a cytokine-induced
differentiation into maturated dendritic cells or antigen presenting
cells,which causes the activation of the immune system. In the pres-
ence of both polymersomes and external cytokines, dendritic cells
are able to differentiate, and this indicates that polymersomes nei-
ther interferewith cell function nor cause an immunologic response
[82]. Alternatively, poly(g-benzyl-L-glutamate)-K polymersomes
loadedwith Inﬂuenza hemagglutinin induced an improved immune
response in mice compared to the free hemagglutinin. However, as
the empty polymersomes were not tested as a necessary control,
the reason for the higher immune response is not clearly related to
the hemagglutinin antigen [80]. Interestingly, it was also reported
that activation of the immune system by dendritic cells can depend
on the size of nano-sized objects, but has not been speciﬁcally
reported for polymersomes [83].
6. Targeting cells with nanoreactors
In addition, successful targeting of the scavenger receptor of
macrophages with ﬂuorescently labeled polymersomes and subse-
quent cellular uptake have been demonstrated [84,85]. After recep-
tor-mediated uptake, the vesicles appeared to escape from the
endosomes, presumably as a result of the ﬁnite miscibility of block
copolymers and lipid membranes [45].
In order to improve uptake and uptake speciﬁcity, polymeric
vesicles have been functionalized with ligands such as polyguanic
acid [84], folic acid [86], tat peptides [82] and antibodies [87]. Most
functionalization studies pertain to polymeric vesicles, with
limited examples extrapolated to nanoreactors. The pioneering
work is related to the functionalization of nanoreactors for target-
ing and relates to trypsin-loaded polymersomes decorated with
polyguanic acid that were speciﬁcally assimilated by THP-1 related
macrophages [45]. Recent studies describe another approach for
speciﬁc uptake using cell-penetrating peptides to decoratenanoreactors containing horseradish peroxidase [35]. Introduction
of functionalities on the surface of nanoreactors is still in early
stages, but essentially all targeting strategies reported for polymer-
somes can be applied to improve uptake of nanoreactors.
7. Conclusion and perspectives
The speciﬁcity and the functioning of organelles are based on
the combination of enzymes/proteins associated with these natu-
ral, complex, lipid-bilayer enclosed compartments. Recently, sig-
niﬁcant efforts have been made to design simpliﬁed, synthetic
organelles capable of functioning inside of cells for the purpose
of both producing drugs and enhancing the function of natural
organelles in pathological conditions. These synthetic organelles
are based on a combination of polymeric vesicles and enzymes/
proteins encapsulated in their cavities. The polymeric vesicle
membrane allows transport of small molecules, such as substrates
and products of enzymatic reaction(s) taking place inside vesicles.
The permeability of the polymer membrane is due either to the
chemical nature of copolymers or to the insertion of channel pro-
teins, in a manner similar to a biological membrane. The advanta-
ges of a polymer membrane are an increase in stability and a lack
of defects as compared to a lipid membrane. These attributes are
also essential to preserving the integrity of nanoreactors inside
cells. The chemistry of amphihilic copolymers permits generating
vesicles of various sizes and properties in order to modulate mem-
brane properties and, in addition, to functionalize vesicles surfaces
for targeting approaches or to improve uptake into cells. The self-
assembly process for vesicles generation and simultaneous encap-
sulation of enzymes can be controlled such that the activity of en-
zymes inside the cavity is preserved, as in organelles. There are
various simultaneous requirements that must be met by a nanore-
actor if it is to serve as an artiﬁcial organelle, seen from the point of
view of morphology, sizes and properties of polymeric vesicles, and
their membranes. An additional requirement for the functioning of
a nanoreactor is that the enzymatic reactions occur in situ. Essen-
tial limitations are imposed by biological conditions in terms of the
toxicity, uptake, and in vitro activity of nanoreactors acting as sim-
pliﬁed synthetic organelles. The use of polymeric nanoreactors as
simpliﬁed models of organelles represents an emerging ﬁeld that
takes advantage of the intelligence exhibited by Nature to propose
novel therapeutic applications.
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